• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Does EPAM’s 2026 EPS Guidance and Buyback-ESOP Moves Change The Bull Case For EPAM (EPAM)?

    Simply Wall St·08/18/2026 19:24:07
    Listen to the news
    • EPAM Systems recently reported second-quarter 2026 results, with revenues of US$1,414.77 million and net income of US$102.98 million, alongside completing a US$632.49 million buyback program that retired 3,801,717 shares, or 7.01% of its outstanding stock under the repurchase plan announced in October 2025.
    • On the same day, the company issued new guidance calling for full-year 2026 GAAP diluted EPS of US$8.22 to US$8.38 and GAAP operating income of 10.5% to 11.0% of revenues, while also filing shelf registrations to issue more than 4.5 million shares tied to employee stock ownership plans.
    • We’ll now examine how EPAM’s updated 2026 earnings guidance and capital actions may influence the existing investment narrative on the company.

    AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    EPAM Systems Investment Narrative Recap

    To own EPAM, you have to believe it can turn its deep engineering and AI capabilities into higher margin, higher value transformation work despite industry and wage pressures. The latest Q2 2026 results and updated 2026 guidance do not materially change that near term catalyst, but they do sharpen focus on execution risk around margins and the need to defend pricing as talent and AI reshape how clients buy digital services.

    The completion of a US$632.49 million buyback that retired 7.01% of outstanding shares sits alongside new shelf registrations for over 4.5 million ESOP related shares. For me, that share count “give with one hand, take with the other” is the most relevant announcement here, because it directly intersects with the earnings per share story many investors are watching as a key near term catalyst.

    Yet behind the promising AI and buyback headlines, investors should be aware that EPAM’s exposure to wage inflation and talent competition could...

    Read the full narrative on EPAM Systems (it's free!)

    EPAM Systems' narrative projects $6.4 billion revenue and $545.5 million earnings by 2029. This requires 4.2% yearly revenue growth and about a $143.8 million earnings increase from $401.7 million today.

    Uncover how EPAM Systems' forecasts yield a $127.94 fair value, a 30% upside to its current price.

    Exploring Other Perspectives

    EPAM 1-Year Stock Price Chart
    EPAM 1-Year Stock Price Chart

    Before this Q2 update, the most optimistic analysts were assuming EPAM could reach about US$7.1 billion of revenue and roughly US$643 million of earnings, which is far more upbeat than consensus. If you are focused on how cost sensitive clients or acquisition integration might pressure margins, today’s guidance and capital moves could easily shift how convincing that bullish story feels, so it is worth comparing these very different viewpoints side by side.

    Explore 7 other fair value estimates on EPAM Systems - why the stock might be worth 7% less than the current price!

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    • A great starting point for your EPAM Systems research is our analysis highlighting 3 key rewards that could impact your investment decision.
    • Our free EPAM Systems research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate EPAM Systems' overall financial health at a glance.

    Ready To Venture Into Other Investment Styles?

    Our daily scans reveal stocks with breakout potential. Don't miss this chance:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.